‘Just Take a Tablet and You’ll be Ok’: Medicalisation, the Growth of Stigma and the Silencing of HIV. by Dalton, Andrew
‘Just take a tablet and you’ll be okay’:
medicalisation, the growth of stigma
and the silencing of HIV
Andrew Dalton
Lecturer in Social Sciences, University of Sunderland
Introduction
This article explores the growth and impact ofthe medicalisation of HIV and HIV-relatedstigma. Since the early days of the virus when
treatments were unavailable, political voices for HIV
advocacy were powerful; public discourse reflected
these changes with growing public-health campaigns
that began to demystify HIV as a concept. However,
with the development of antiretroviral therapy (ART)
the voices powerfully associated with HIV have
largely moved away from the campaign and
advocacy groups, having switched to, and accruing
dominance from, the biomedical establishment
through the medicalisation of HIV. This has led to a
parallel system in which people today are living
longer with HIV treatment and their standards of living
are getting better; however, the once powerful process
of demystification and public discourses discussing
HIV and its stigma, have become much more muted.
HIV in the public realm has become largely ‘silenced’
outside the work of HIV organisations and biomedical
institutions and so has yet to develop into a ‘post-HIV’
stage of public understanding and acceptance. This
article uses the work of Ghaziani and applies his
three-stage model of community change, arguing that
HIV as a concept has not begun the final stage of
acceptance where HIV stigma is tackled through
public discourse because of the medicalisation process
itself [1].
What is stigma?
Stigma is wrapped up in sociocultural and historical
processes, and alters and changes over time. Stigma
is defined as the occurrence of ‘labelling, stereotyping,
separation, status loss, and discrimination in a context
in which power is exercised’. It overlaps with
discrimination and racism for example, but it differs
from these in some respects [2]. What sets stigma apart
from discrimination is that it incorporates other
elements such as labelling and stereotyping, shame,
status loss and the process of discrimination [2].
Indeed, discrimination only becomes an effect, or
manifestation, of stigma when society defends or
encourages it [3], and so it is not always an inevitable
outcome of stigma [4].
It is vital to recognise that stigmatisation works on
many levels, it can be overt and manifest as aversion,
avoidance, social rejection, dehumanisation,
discounting and turning others into stereotypical
characters [5]. However, it can also be subtler than
this and arise through non-verbal expressions of
discomfort such as a lack of eye contact and creating
tense social interactions [6]. Stigma is not a recent
concept. The word ‘stigma’ dates to the ancient Greeks
who would brand criminals, slaves and traitors to
identify them as tainted or immoral people who should
be avoided [7]. This combination of socio-historical
attitudes and shifting cultural attitudes in a globalised
world has shown stigma to be a global psychosocial
phenomenon [8].
In his seminal work, Goffman [7] argued that stigma
is an attribute that serves to discredit an individual
or group. It operates by tainting and diminishing them,
rendering them abject and inferior and he drew on
the examples of ‘orphan’ or ‘criminal,’ to show how
these statuses can engender negative stereotypes [9].
Stigma is associated with ‘abominations of the flesh’,
the soul and the tribe (deviant bodies, deviancy
mentally/behaviourally and ethnic/national
characteristics). Goffman argues that these are either
controllable or uncontrollable, as well as visible and
invisible. Individuals with visible deviant characteristics
are deemed to have ‘discredited’ stigma, displaying
visible signs of difference and those who have invisible
‘discreditable’ characteristics can pass as ‘normal’ but
they must manage the risks associated with this.
Individuals with discreditable characteristics fear their
characteristic being discovered [7,10]. Although stigma
is often presented as something that resides within
the individual, it is more a language of relationships
rather than attributes, and as a result, changes over
time, and is salient depending on what is regarded
as normal or acceptable in particular social contexts.
Goffman termed those who do not have a stigmatic
characteristic ‘normal’ and those who are ‘normal’
experience their bodies as absent, or unproblematic,
and so stigma creates a boundary between ‘us’ and
‘them’, confirming a moral superiority of the
stigmatising group and reinforcing their claim to
normalcy. Importantly, the stigmatising of ‘others’ is
an identity-producing practice. Normal identity, which
does not deviate from social expectations, is produced
through the enactment of exclusionary practices [11].
In the literature on deviance other authors have
clarified links to the process of stigma itself. Mankoff,
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for example, made a distinction between ‘ascribed’
and ‘achieved deviance’ [12]. Ascribed deviance is
a condition attributed to individuals for which they
are not held accountable and so no blame is
attached. Achieved deviance sets out the notion that
the individual is in some way culpable for their
condition. Blindness could be regarded as an ascribed
deviance and HIV, through its sexual transmission,
as achieved deviance. However, Mankoff did not
account for the significant overlap between the two.
Blindness may be caused by a mishap on the part
of a careless individual and so their behaviour is
judged irresponsible and thus implicated in their
condition. Similarly, children born with HIV may have
their deviance ascribed; however, they are not
blamed for it. Weiner’s ‘attribution theory’ argues that
perceiving a cause as uncontrollable and judging an
individual as responsible leads to negative emotions
and avoidance behaviours [13,14]; although,
perceiving a cause as uncontrollable and de-
individualising it, elicits positive emotions and
approach behaviours. Part of addressing illness- and
disease-related stigma is through campaigns to reduce
stigma in the public consciousness; however, the
effectiveness of some campaigns is hit and miss. In
fact, anti-stigmatising campaigns that emphasised
individual biomedical, rather than psychosocial
explanations, did not reduce stigma and in some
cases increased it [15].
As well as links to deviance and reinforcement of
social norms, numerous studies have identified that
stigma internalised by individuals has detrimental
consequences on the psychological wellbeing of those
who are stigmatised [16,17]. ‘Self-stigma’ results from
an acute awareness of a stigmatised person’s own
social devaluation connected to their condition or
illness and, like public stigma, it has cognitive and
behavioural components [5]. Self-stigma can be part
of a ‘felt’ process and leads to individuals hiding
aspects of their condition (or the condition entirely)
from others and being receptive to perceived ideas
of shame and guilt for their condition.
Stigma and deviance can be either ‘enacted’ or ‘felt’.
Enacted stigma and deviance ‘denote discrimination
by others, felt stigma and deviance denote: (1) an
internalised sense of shame and blame respectively;
and (2) a frequently distressing and disruptive fear
of being discriminated against’ [18]. In terms of ‘hidden’
illnesses, individuals may manage their illness and
information about it with extreme caution in order
to pass as normal [10]
Well-established theories on the self, such as symbolic
interactionism [19], social comparison theory [20] and
social identity theory [21], suggest and predict that
public stigma should exert direct influences onto
self-stigma. In certain circumstances and contexts,
people may gain status (and thus self-status) if they
come out about a stigmatised characteristic and so
they become legitimate spokespeople for marginalised
groups in the process. The stigmatisation can become
the foundation of a minority group identity and so
establishes the group’s legitimacy for lobbying for
political change. In doing so, an individual or group’s
confidence can develop by using their own
stigmatised status to gain social progress or reward,
which has been seen in the growth of the HIV activist
movement that began in the 1980s.
This is not always a straight forward process and as
Goffman argued [7], people who choose to ‘pass’ as
‘normal’ by hiding their stigma still remain
‘discreditable’ for as long as the potential for stigma
to be revealed persists, which may lead to significant
distress amongst those who conceal their condition.
When people voluntarily disclose their stigmatised
status or when they have a visible stigma (such as
an obvious physical disability) they do not face the
issues around disclosure, but they must still endure
the potential for being discredited in front of others
[22]. Stigmatised individuals can attempt to mitigate
the negative effects of this by employing coping
strategies such as selective disclosure, compensating
for the stigma during social interactions (for example,
by being particularly outgoing) and through
disengagement (avoiding situations where
stigmatisation is more likely) [5]. Others may use
dif ferent coping methods, such as being more
politically aligned by seeking or setting up social
support, as people living with an invisible stigmatised
condition experience a mood lift in the presence of
others who share their stigma [2]. This is also seen,
in some cases, by alignment with others in social,
political or community (or public facing) groups [23].
What is meant by
medicalisation and how is it
linked to HIV-related stigma?
Conrad [24] argued that the process of medicalisation
is to ‘make medical.’ Something such as HIV becomes
a problem primarily ‘defined in medical terms,
described using medical language, understood
through the adoption of a medical framework, or
“treated” with medical intervention’. Stigmatisation is
itself an important part of the history of any particular
epidemic. It is a social process: a feature of social
relations, reflecting the tension, conflict, silence,
subterfuge and hypocrisy found in every human
society and culture [25]. HIV-related stigma is ‘a term
that refers to prejudice, discounting, discrediting, and
discrimination directed at people perceived to have
AIDS or HIV, and the individuals, groups, and
communities with which they are associated’ [26]. This
stigma is commonly understood as a process of
devaluation that can have many outcomes, for
example direct discrimination, also known as ‘enacted
stigma’ [18]. Furthermore, in the context of HIV, stigma
can adversely affect how and when someone
physically accesses services, including testing, support
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and treatment. It also affects how people interact with
each other, including friendships, intimate partnerships
and professional relationships, and how someone
perceives themselves and their self-esteem [27].
Initial government and media-related scare tactics,
such as the UK’s ‘Don’t Die of Ignorance’ (1987)
public-health campaign, and the public fear they
triggered, helped to form early HIV-related stigma that
has continued throughout the epidemic, particularly
towards certain groups. From the moment scientists
identified HIV and AIDS, public responses of fear,
denial, stigma and discrimination have accompanied
it (see www.avert.org [28]). Discrimination spread
rapidly, fuelling anxiety and prejudice towards the
groups most affected, that is, men who have sex with
men (MSM) in general, and those living with HIV or
AIDS. HIV and AIDS are, therefore, as much about
social phenomena as they are about biological and
medical concerns. This is argued by Altman [25] who
highlighted that HIV and AIDS mixes sex, death, fear
and disease in ways that can be interpreted to suit
the prejudices and agendas of those ‘controlling
particular historical narratives in any specific time or
place. Fear of infection all too easily translates into
fear of the infected. The disease has been used to
stigmatise various out-groups’ [25]. The uncertainty
and disagreements about the cause, scale and
consequences of the virus led to a fracturing of
medico-scientific progress as set out under modernity
[29].
AIDS was regarded as a ‘disease’ of lifestyle and
‘commentators were quick to moralise about the
actions of particular social groups’ [29]; some scientists
presented ‘fast-lane gay lifestyles’ as the cause of AIDS.
In the early 1980s the disease was even labelled GRID
(gay-related immune deficiency) by some scientists.
Owing to the confusion of scientific establishments and
governments who denied or did not act, consumer
activism developed in this space as HIV/AIDS became
politicised as ‘life politics’ [30]. In place of traditional
politics from institutions, life politics became something
that was more personalised as people pursued issues
close to their own lives and would not passively
accept authority (from medical establishments or
governments, for example). Although these are
personal politics, they are also global, as HIV/AIDS
saw alliances forged in the global arena.
People diagnosed with HIV/AIDS before 1996 lived
in a climate of death and many expected to die. The
introduction of ART in 1996 meant that ‘patients who
had resigned themselves to death, cashed in life
insurance policies, and given up employment found
themselves granted a new lease of life’ [31]. In what
became known widely as ‘Lazarus syndrome’ [25],
people who had believed that they were going to
die through lack of effective treatment or highly toxic
trial drugs, now had a second chance through ART
medication. This led to a rapid reclassification of HIV
and AIDS by the World Health Organization in terms
of severity and HIV is now classified as a chronic
illness, along the same lines as diabetes [32]. In the
same year in which ART became widely available
to people living with HIV (PLWH) and AIDS, post-
exposure prophylaxis (PEP) with antiretrovirals was
also recommended to healthcare workers exposed
to needle-stick injuries and later to the public.
Conversely, while biomedical developments have
been important for those living with HIV, there has
been a shift in cultural beliefs so that HIV/AIDS
discourses are now the domain of science through
the advancement of medication, and to a lesser
extent, (falsely) media-reported ‘cures’. This leads away
from the social and cultural issues of stigma that still
need to be addressed. HIV/AIDS has become a
‘problem of the body alone’ and is a problem to be
solved almost exclusively by medical science, clinical
practices, epidemiological knowledge and the
behavioural intentions that affect the ways that bodies
behave toward each other [25]. The impact of
discrimination, this shift from public to scientific
discourse (and thus silencing of the discussion as it
is left to medical experts) and HIV-related stigma is
still prevalent.
HIV-related stigma in contemporary Britain has not
abated; it has increased. A silencing of public
discourse on HIV/AIDS has developed because
medical discourse dominates HIV/AIDS. This silencing
of HIV/AIDS has become a key point. Knowledge and
public awareness of HIV is on the decline and owing
to this, older cultural memories of HIV/AIDS have held
firm [33]. Biomedical advances have changed the
course of HIV for the better, while HIV-related stigma
has stayed within early social constructs around it.
While early comprehensive policies were put into
place at a UK level and had a significant response
globally, the emergence of ART significantly changed
the social fabric of dealing with HIV/AIDS.
The National AIDS Trust (NAT) published a longitudinal
study into ‘Public knowledge and attitudes toward
HIV’ in 2014, in the UK [33]. However, while the report
suggested that the public is now more aware that
HIV-related stigma exists and believes that more needs
to be done about it, it also highlighted social attitudes,
for example, one in 10 people do not have much
sympathy for PLWH. This increased to three in 10 if
a person was infected through unprotected sex. This
is a concern because by far the most common form
of transmission among people diagnosed with HIV
in 2014, just before the survey was undertaken, was
through unprotected sex (95%). Other results from the
survey highlighted workplace HIV-related stigma: just
over two-thirds (67%) of respondents were comfortable
working with a colleague living with HIV. The report
also showed incorrect transmission knowledge, as one
in 10 (10%) respondents incorrectly believed HIV could
be transmitted through spitting, almost one-third (28%)
believed HIV could be transmitted through biting and
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almost half believed HIV could be transmitted by a
blood transfusion in the UK (49%). The report went
on to state that the sizeable proportion who responded
with ‘don’t know’ to these statements indicated that
some members of the public were quite aware that
their knowledge about HIV was limited [33]. The
number of PLWH in the UK trebled between 2003 and
2013 [34] but over the same period, there was a
significant decline in public knowledge about how
HIV is transmitted. Public attitudes have not kept pace
with improvements in treatment.
Many people continue to hold stigmatising attitudes
to PLWH [3]. Alongside these attitudes come a range
of difficulties and constant challenges in daily life,
which include living with noxious symptoms, side
effects from treatments, periods of disability,
unemployment, isolation from social networks and
poverty [35]. HIV-related discrimination and public
perceptions of HIV are the largest handicaps to living
well with HIV. They extend to all areas of life and
many people experiencing double discrimination as
a result of their ethnicity or sexuality [36]. In a survey
by the Positively UK [37], three-quarters of respondents
living with HIV stated that they had suffered from
either depression, anxiety or ongoing emotional
distress in the past 12 months, with 40% of respondents
experiencing discrimination in the past 12 months due
to their HIV-positive status. Other results from this
survey back up the findings by NAT, revealing that
PLWH are least willing to disclose their positive status
to work colleagues, with four out of 10 respondents
preferring not to disclose their positive status [33].
Whether discrimination did occur at work, the
perception was that there was a real danger that they
would be discriminated against.
There have been no UK, nationwide government-
funded public health campaigns since 1987 and HIV
has increased substantially since that time as
‘ignorance of how to prevent HIV is still vast and in
the absence of public health education campaigns
it has increased over the last twenty years’ [38].
However, each new generation of individuals needs
to be educated to continue to lower the risk of HIV
infection [39]. This is increasingly difficult to maintain
due to austerity measures and because few resources,
other than those from the voluntary sector, are being
used to push a large-scale HIV/AIDS-specific
prevention and stigma message [40].
Further research has shown that stigma has
discouraged or deterred people from being tested for
HIV, disclosing their status to others, seeking
information and maintaining medical regimens [41],
and many education and prevention programmes
rarely address HIV-related stigma. Schools have been
accused of offering haphazard sex-education classes
as ‘recent sexual health campaigns – especially those
aimed at young people – have made no mention of
it at all. Young people rarely learn about HIV in
schools’ [42] Yet, interestingly, the vast majority (86%)
of members of the public agree that all young people
should be taught about HIV at secondary school to
ensure they have a good understanding of the
condition by the time they leave [33,43]. In all, HIV
is becoming a silent virus within modern Britain, yet
those who are living with it, and increasingly infected
by it, have clearer needs other than just medical
treatment if the social exclusion and stigma, which
has existed from the emergence of the virus, is to be
tackled.
A post-HIV stage?
A fuller picture and model of the nature of
medicalisation and the growth of HIV stigma can be
analysed using the work of Ghaziani and his
exploration of ‘gaybourhoods’ [1]. While Ghaziani’s
model focuses on geographical, social and economic
gaybourhoods – that is, geographical and social-lived
neighbourhoods of LGBT people – his identification of
three changing historical characteristics can be
transferred to the growth and development of HIV.
Ghaziani discusses the following changing stages of
sexual history in the West:
(1) Closet: a stage typified by fear, hostility and
aggression toward LGBT people. This stage is more
insular and fragmented, with some small pockets
of resistance to social norms;
(2) Coming out: a shift into geographical
gaybourhoods and the movement of LGBT bodies
into a political process to fight larger oppressive
policies and to bring lived LGBT experiences to
light; and
(3) Post gay: due to shifting social forces and attitudes,
this stage sees a dispersal of LGBT people into the
‘general’ population as gaybourhoods begin to
transform and/or disappear.
Ghaziani’s model becomes a useful framework to
discuss the shifting attitudes toward HIV from its
appearance on the world stage in 1981 onwards. This
is touched on by Flowers [44] who constructs a
framework for how ‘risk’ was managed in relation to
UK gay men by the identification of three key stages.
Stage one refers to the 1980s as a ‘confused’ period
with a general climate of fear. A second ‘somatic’
period emerged of risk management, from the
mid-1980s to the 1990s, when it was discovered that
HIV was associated with AIDS. The ‘management of
bodies’ came to the fore at this point [44], via health
promotion programmes asking people to act
responsibly and rationally while ‘other’ discrete bodies
– those who were tested and diagnosed as living with
HIV and those who were untested and engaging in
risky behaviours, were to be avoided. Towards the
early 2000s, the third stage emerged as a
‘technological period’ where the advent of new drug
treatments and testing technologies to monitor HIV
viral activity, added a new dimension to risk
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management. This risk management has been placed
in the hands of medical practitioners, which has had
the effect of fracturing the HIV community, volunteer
support systems and activism that characterised the
earlier confused period.
Transposing Ghaziani’s model onto the history of HIV,
the developments and social shifts of HIV stigma have
accomplished the first two stages of this model: a
general fear and confused period leading to the
activist groups and HIV campaigns that resulted in
the survival work of trying new medications, drug
trials and the development of technologies. However,
this has proved to be a double-edged sword as the
forces of medicalisation and medical narratives have
taken dominance in the treatment of PLWH (which
was to be expected when ART became available),
but wider public stigma towards HIV has not tackled.
As such, what I call a post-HIV stage [45] has not been
accomplished. This should have run alongside the
technological period of advancement. The post-HIV
stage means that there should have been a significant
shift in public attitudes to allow PLWH to be less
stigmatised as well as an awareness among the
general population not living with HIV, about the facts,
stigmas and knowledge of what HIV is and how it
can be transmitted. The medicalisation of HIV has
contributed to a silencing of HIV within wider public
discourse because of the medical dominance of HIV
discussion and treatment as prevention [46]. This
ignores the stigma accompanying the virus. All too
frequently, in discussions of HIV, a medical model of
a ‘cure’ or a new treatment is highlighted, which
leaves little room for the voices of HIV activists and
PLWH to be heard away from the medical realm thus
blocking progress in dealing with wider stigma around
the virus. A direct consequence of this has been the
growth of HIV-related stigma and stigmatising
attitudes within wider society, the silencing of HIV
discussion outside those living with HIV and the
medical remit, and the stalling of stigma from entering
a post-HIV stage.
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